Skip to content
Disclosery

SILVERARC CAPITAL MANAGEMENT, LLC

Follow

13F filer, CIK 1816307, BOSTON, MA

SILVERARC CAPITAL MANAGEMENT, LLC reported $542,288,634 across 65 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 54.97% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-25-002146

Period
2025-06-30
Reported value
$542M
Holdings
65
Top 10 weight
54.97%
New
19
Sold out
23

Part of the filer group SILVERARC CAPITAL MANAGEMENT, LLC

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CGONnew+541,034$14.1M
SRRKnew+341,010$12.1M
NBIXadded+90,386$11.4M
PCVXnew+287,796$9.36M
URGNadded+641,324$8.79M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VERONA PHARMA PLCreduced-187,575-$17.7M
NUVLreduced-203,435-$15.5M
IRONexited-236,471-$11.7M
SNDXreduced-906,260-$8.49M
WVEexited-1,050,374-$8.49M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001420506-25-002146, largest first. % of portfolio is the value over $488,616,503, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 635,439 shares; 2024Q4: 680,845 shares; 2025Q1: 811,021 shares; 2025Q2: 741,972 shares 741,972$39M7.99%-69,049
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 639,840 shares; 2024Q4: 739,563 shares; 2025Q1: 719,992 shares; 2025Q2: 713,811 shares 713,811$38.1M7.8%-6,181Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 348,866 shares; 2024Q4: 516,014 shares; 2025Q1: 545,872 shares; 2025Q2: 358,297 shares 358,297$33.9M6.94%-187,575
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 901,129 shares; 2024Q4: 1,120,473 shares; 2025Q1: 1,381,158 shares; 2025Q2: 2,022,482 shares 2,022,482$27.7M5.67%+641,324Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 255,578 shares; 2024Q4: 273,896 shares; 2025Q1: 337,605 shares; 2025Q2: 400,772 shares 400,772$25.3M5.18%+63,167Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 347,695 shares; 2024Q4: 372,230 shares; 2025Q1: 321,366 shares; 2025Q2: 249,060 shares 249,060$25.1M5.13%-72,306Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 574,558 shares; 2024Q4: 612,173 shares; 2025Q1: 1,698,984 shares; 2025Q2: 1,832,171 shares 1,832,171$20.7M4.24%+133,187Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 72,583 shares; 2025Q2: 162,969 shares 162,969$20.5M4.19%+90,386Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 92,298 shares; 2024Q4: 96,511 shares; 2025Q1: 1,510,498 shares; 2025Q2: 2,037,087 shares 2,037,087$20M4.09%+526,589
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,099,490 shares; 2024Q4: 1,178,300 shares; 2025Q1: 2,060,240 shares; 2025Q2: 1,800,829 shares 1,800,829$18.3M3.74%-259,411Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 371,441 shares; 2024Q4: 400,014 shares; 2025Q1: 439,018 shares; 2025Q2: 235,583 shares 235,583$18M3.68%-203,435Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 166,417 shares; 2025Q2: 204,591 shares 204,591$17.1M3.51%+38,174Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,000 shares; 2024Q4: 51,491 shares; 2025Q1: 75,751 shares; 2025Q2: 86,552 shares 86,552$14.9M3.06%+10,801Timeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 541,034 shares 541,034$14.1M2.88%newTimeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 470,565 shares; 2024Q4: 503,281 shares; 2025Q1: 633,832 shares; 2025Q2: 448,495 shares 448,495$12.1M2.48%-185,337Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 183,243 shares; 2025Q1: not reported; 2025Q2: 341,010 shares 341,010$12.1M2.47%newTimeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 475,555 shares; 2024Q4: 543,651 shares; 2025Q1: 411,312 shares; 2025Q2: 410,000 shares 410,000$11.6M2.38%-1,312Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,500 shares; 2024Q4: 40,788 shares; 2025Q1: not reported; 2025Q2: 287,796 shares 287,796$9.36M1.91%newTimeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 344,338 shares 344,338$8.35M1.71%newTimeline
HELIX ACQUISITION CORP IIHELIX ACQUISITION CORP IIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 513,369 shares; 2024Q4: 513,369 shares; 2025Q1: 613,393 shares; 2025Q2: 613,393 shares 613,393$6.51M1.33%0
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,645,352 shares; 2024Q4: 6,171,847 shares; 2025Q1: 6,320,684 shares; 2025Q2: 5,146,782 shares 5,146,782$6.33M1.3%-1,173,902Timeline
MTSRMETSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 112,759 shares; 2025Q2: 207,581 shares 207,581$5.91M1.21%+94,822Timeline
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,645,808 shares; 2024Q4: 1,782,271 shares; 2025Q1: 2,670,056 shares; 2025Q2: 2,761,684 shares 2,761,684$5.47M1.12%+91,628Timeline
CGENCOMPUGEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,501,113 shares; 2024Q4: 1,624,377 shares; 2025Q1: 2,895,430 shares; 2025Q2: 3,033,879 shares 3,033,879$5.4M1.11%+138,449Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,124,928 shares; 2024Q4: 3,065,649 shares; 2025Q1: 2,771,288 shares; 2025Q2: 2,779,795 shares 2,779,795$5.39M1.1%+8,507Timeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 917,898 shares 917,898$5.21M1.07%newTimeline
CDTXCIDARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 103,943 shares 103,943$5.06M1.04%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 145,000 shares; 2024Q4: 264,560 shares; 2025Q1: 205,962 shares; 2025Q2: 198,441 shares 198,441$4.04M0.83%-7,521Timeline
AARDAARDVARK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 119,496 shares; 2025Q2: 286,807 shares 286,807$3.88M0.79%+167,311Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 82,023 shares 82,023$3.87M0.79%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 378,746 shares; 2024Q4: 1,230,400 shares; 2025Q1: 1,309,224 shares; 2025Q2: 402,964 shares 402,964$3.77M0.77%-906,260Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 70,516 shares; 2024Q4: 152,395 shares; 2025Q1: 188,069 shares; 2025Q2: 175,636 shares 175,636$3.64M0.75%-12,433Timeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,495,329 shares; 2024Q4: 1,587,228 shares; 2025Q1: 2,456,537 shares; 2025Q2: 2,488,291 shares 2,488,291$3.51M0.72%+31,754Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,946,488 shares; 2024Q4: 7,543,901 shares; 2025Q1: 7,367,996 shares; 2025Q2: 2,569,591 shares 2,569,591$3.26M0.67%-4,798,405Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 874,869 shares; 2025Q2: 1,249,781 shares 1,249,781$3.25M0.67%+374,912Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 114,138 shares; 2025Q2: 186,015 shares 186,015$3.23M0.66%+71,877Timeline
BNTCBENITEC BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 250,000 shares; 2025Q2: 253,234 shares 253,234$2.96M0.61%+3,234Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 482,575 shares; 2024Q4: 734,234 shares; 2025Q1: 530,000 shares; 2025Q2: 539,587 shares 539,587$2.95M0.6%+9,587Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 100,000 shares; 2025Q1: 203,400 shares; 2025Q2: 202,565 shares 202,565$2.82M0.58%-835Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 88,215 shares; 2025Q2: 75,959 shares 75,959$2.1M0.43%-12,256Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 165,389 shares 165,389$1.85M0.38%newTimeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 190,334 shares; 2025Q2: 95,806 shares 95,806$1.78M0.37%-94,528Timeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 109,257 shares 109,257$1.75M0.36%new
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 338,354 shares; 2025Q2: 115,282 shares 115,282$1.56M0.32%-223,072Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 500,000 shares; 2024Q4: 1,000,000 shares; 2025Q1: 441,807 shares; 2025Q2: 401,540 shares 401,540$1.5M0.31%-40,267Timeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 155,325 shares; 2025Q1: 191,470 shares; 2025Q2: 103,026 shares 103,026$1.4M0.29%-88,444Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,585,786 shares; 2024Q4: not reported; 2025Q1: 3,088,505 shares; 2025Q2: 3,128,421 shares 3,128,421$926K0.19%+39,916
RADXRADIOPHARM THERANOSTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 187,406 shares; 2025Q1: 187,406 shares; 2025Q2: 187,406 shares 187,406$870K0.18%0Timeline
MODDMODULAR MED INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,440,000 shares; 2024Q4: 1,272,015 shares; 2025Q1: 958,881 shares; 2025Q2: 710,363 shares 710,363$529K0.11%-248,518Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 67,045 shares; 2024Q4: 72,516 shares; 2025Q1: 166,074 shares; 2025Q2: 10,000 shares 10,000$420K0.09%-156,074Timeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 166,666 shares; 2024Q4: 176,922 shares; 2025Q1: 237,448 shares; 2025Q2: 202,590 shares 202,590$328K0.07%-34,858Timeline
BIODESIX INCBIODESIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,561,094 shares; 2024Q4: 4,332,281 shares; 2025Q1: 4,098,406 shares; 2025Q2: 1,070,367 shares 1,070,367$302K0.06%-3,028,039
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,539 shares 37,539$286K0.06%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares 10,000$201K0.04%newTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 744,592 shares; 2024Q4: 598,952 shares; 2025Q1: 232,758 shares; 2025Q2: 5,000 shares 5,000$65.7K0.01%-227,758Timeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 346 shares 346$8.94K<0.01%newTimeline
RCKTWROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 104,828 shares; 2024Q4: 104,828 shares; 2025Q1: 104,828 shares; 2025Q2: 104,828 shares 104,828$3.02K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MERUS N VMERUS N V CALL DEcall382,500$20.1Mnew
SPDR SERIES TRUSTSPDR SERIES TRUST ST STR SP BIOTcall200,000$16.6Mnew
NUVALENT INCNUVALENT INC Equity Callcall100,200$7.65Mnew
COGENT COMM HOLDINGS INCCOGENT COMM HOLDINGS INC COM NEWcall500,000$3.59Mnew
HIMS & HERS HEALTH INCHIMS & HERS HEALTH INC PUTput50,000$2.49Mnew
CAPRICOR THERAPEUTICS INCCAPRICOR THERAPEUTICS INC COM NEWput144,700$1.44Mnew
AKERO THERAPEUTICS INCAKERO THERAPEUTICS INC CALLcall25,000$1.33M-155,600
SYNDAX PHARMACEUTICALS INCSYNDAX PHARMACEUTICALS INC COMcall50,000$468Knew

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
IRONDISC MEDICINE INC236,471$11.7Mshares
WVEWAVE LIFE SCIENCES LTD1,050,374$8.49Mshares
TVTXTRAVERE THERAPEUTICS INC408,849$7.33Mshares
GILDGILEAD SCIENCES INC62,029$6.95Mshares
TARSTARSUS PHARMACEUTICALS INC81,331$4.18Mshares
ALKSALKERMES PLC124,871$4.12Mshares
OCULOCULAR THERAPEUTIX INC551,570$4.04Mshares
BBIOBRIDGEBIO PHARMA INC111,000$3.84Mshares
KURAKURA ONCOLOGY INC581,369$3.84Mshares
MDGLMADRIGAL PHARMACEUTICALS INC10,344$3.43Mshares
BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP37,345$3.31Mshares
LQDALIQUIDIA CORPORATION214,057$3.16Mshares
PTCTPTC THERAPEUTICS INC60,389$3.08Mshares
SOLENO THERAPEUTICS INCSOLENO THERAPEUTICS INC42,500$3.04Mput
SLDBSOLID BIOSCIENCES INC452,239$1.67Mshares
CCCCC4 THERAPEUTICS INC882,300$1.41Mshares
KALAKALA BIO INC246,079$1.41Mshares
UNICYCIVE THERAPEUTICS INCUNICYCIVE THERAPEUTICS INC2,413,489$1.39Mshares
ABVXABIVAX SA210,901$1.32Mshares
IFRXINFLARX NV1,161,567$1.18Mshares
XENEXENON PHARMACEUTICALS INC10,121$340Kshares
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALS39,366$308Kshares
VXRTVAXART INC COM NEW (DE)683,825$278Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-25-002146 base2025-08-14acceptance time not in the bulk data set